Hologic Financial Statements (HOLX)
|
|
|
|
Report date
|
|
|
30.09.2023 |
21.11.2023 |
30.09.2024 |
27.11.2024 |
18.11.2025 |
|
29.01.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
4 030 |
4 030 |
|
4 030 |
4 101 |
|
4 126 |
|
Operating Income, bln rub |
|
|
668.4 |
668.4 |
|
882.6 |
714.3 |
|
721.6 |
|
EBITDA, bln rub |
? |
|
1 204 |
1 111 |
|
1 296 |
1 024 |
|
1 014 |
|
Net profit, bln rub |
? |
|
456.0 |
456.0 |
|
789.5 |
565.7 |
|
543.9 |
|
|
OCF, bln rub |
? |
|
1 051 |
1 051 |
|
1 285 |
1 057 |
|
1 098 |
|
CAPEX, bln rub |
? |
|
150.2 |
150.2 |
|
140.2 |
137.0 |
|
98.1 |
|
FCF, bln rub |
? |
|
901.0 |
901.0 |
|
1 145 |
920.1 |
|
999.6 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
|
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
|
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
|
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
1 310 |
1 403 |
|
1 345 |
1 787 |
|
1 458 |
|
Cost of production, bln rub |
|
|
1 959 |
1 959 |
|
1 803 |
1 599 |
|
1 947 |
|
R&D, bln rub |
|
|
294.3 |
294.3 |
|
272.8 |
248.2 |
|
248.5 |
|
Interest expenses, bln rub |
|
|
111.1 |
111.1 |
|
122.1 |
42.7 |
|
95.2 |
|
|
Assets, bln rub |
|
|
9 139 |
9 139 |
9 156 |
9 156 |
9 015 |
|
9 181 |
|
Net Assets, bln rub |
? |
|
5 017 |
5 017 |
5 130 |
5 130 |
5 048 |
|
5 245 |
|
Debt, bln rub |
|
|
2 818 |
2 904 |
2 535 |
2 658 |
2 627 |
|
2 520 |
|
Cash, bln rub |
|
|
2 723 |
2 723 |
2 334 |
2 334 |
2 203 |
|
2 365 |
|
Net debt, bln rub |
|
|
95.7 |
181.6 |
201.0 |
324.4 |
424.1 |
|
155.6 |
|
|
Ordinary share price, rub |
|
|
69.4 |
69.4 |
81.5 |
81.5 |
|
|
76.0 |
|
Number of ordinary shares, mln |
|
|
246.8 |
246.8 |
|
235.7 |
227.2 |
|
224.4 |
|
|
Market cap, bln rub |
|
|
17 126 |
17 126 |
0 |
19 202 |
0 |
|
17 057 |
|
EV, bln rub |
? |
|
17 222 |
17 308 |
201 |
19 526 |
424 |
|
17 213 |
|
Book value, bln rub |
|
|
5 017 |
847 |
5 130 |
842 |
818 |
|
1 053 |
|
|
EPS, rub |
? |
|
1.85 |
1.85 |
|
3.35 |
2.49 |
|
2.42 |
|
FCF/share, rub |
|
|
3.65 |
3.65 |
|
4.86 |
4.05 |
|
4.45 |
|
BV/share, rub |
|
|
20.3 |
3.43 |
|
3.57 |
3.60 |
|
4.69 |
|
|
EBITDA margin, % |
? |
|
29.9% |
27.6% |
|
32.2% |
25.0% |
|
24.6% |
|
Net margin, % |
? |
|
11.3% |
11.3% |
|
19.6% |
13.8% |
|
13.2% |
|
FCF yield, % |
? |
|
5.26% |
5.26% |
0.00% |
5.96% |
|
|
5.86% |
|
ROE, % |
? |
|
9.09% |
9.09% |
0.00% |
15.4% |
11.2% |
|
10.4% |
|
ROA, % |
? |
|
4.99% |
4.99% |
0.00% |
8.62% |
6.28% |
|
5.92% |
|
|
P/E |
? |
|
37.6 |
37.6 |
|
24.3 |
0.00 |
|
31.4 |
|
P/FCF |
|
|
19.0 |
19.0 |
|
16.8 |
0.00 |
|
17.1 |
|
P/S |
? |
|
4.25 |
4.25 |
|
4.76 |
0.00 |
|
4.13 |
|
P/BV |
? |
|
3.41 |
20.2 |
0.00 |
22.8 |
0.00 |
|
16.2 |
|
EV/EBITDA |
? |
|
14.3 |
15.6 |
|
15.1 |
0.41 |
|
17.0 |
|
Debt/EBITDA |
|
|
0.08 |
0.16 |
|
0.25 |
0.41 |
|
0.15 |
|
|
R&D/CAPEX, % |
|
|
195.9% |
195.9% |
|
194.6% |
181.2% |
|
253.3% |
|
|
CAPEX/Revenue, % |
|
|
3.73% |
3.73% |
|
3.48% |
3.34% |
|
2.38% |
|
| Hologic shareholders |
